True Vision MN’s Aptus Defined Risk ETF DRSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-63,789
Closed -$1.82M – 102
2025
Q4
$1.82M Sell
63,789
-759
-1% -$22.2K 0.92% 26
2025
Q3
$1.86M Sell
64,548
-1,053
-2% -$30.3K 0.97% 25
2025
Q2
$1.89M Sell
65,601
-3,075
-4% -$85.1K 1.04% 25
2025
Q1
$1.87M Buy
68,676
+748
+1% +$20.8K 1.12% 24
2024
Q4
$1.86M Buy
67,928
+4,173
+7% +$117K 1.11% 22
2024
Q3
$1.8M Buy
63,755
+6,486
+11% +$180K 1.08% 22
2024
Q2
$1.55M Buy
+57,269
New +$1.52M 1.01% 23

Other funds holding DRSK

True Vision MN's DRSK Position: Q1 2026 in Review

True Vision MN sold out of Aptus Defined Risk ETF (DRSK) in Q1 2026, closing a stake of 63,789 shares — an estimated $1.82M sold.

True Vision MN first reported a position in DRSK in Q2 2024 and held it in 7 quarters. The position peaked at $1.89M in Q2 2025. 89 funds tracked by Wall St. Rank hold DRSK as of Q1 2026.

  • True Vision MN reported no remaining Aptus Defined Risk ETF position as of Q1 2026 after selling out during the quarter.
  • True Vision MN sold 63,789 Aptus Defined Risk ETF shares in Q1 2026, an estimated $1.82M.
  • True Vision MN first reported a position in Aptus Defined Risk ETF in Q2 2024 and held it in 7 quarters.
  • True Vision MN's Aptus Defined Risk ETF position peaked at $1.89M in Q2 2025.
  • 89 funds tracked by Wall St. Rank held Aptus Defined Risk ETF as of Q1 2026.

Based on True Vision MN's 13F filing for Q1 2026, filed 16 Apr 2026.